Common symptoms of glaucoma include eye pain, severe headaches, patchy spots in or blurring of vision, halos around light, eye redness, nausea and vomiting, and tunnel vision in the late stages.
To catch glaucoma in the early stages, the American Academy of Ophthalmology’s recommendation is screenings for glaucoma each four years after age 40 and each two years after age 60.
Other recommendations state that if you are over age 40 and have a family history of glaucoma, you should get a complete exam from an eye doctor every one to two years. If you suffer from health problems such as diabetes or are at risk for other eye diseases, it may be necessary to go more often.
The research team is now planning to enter clinical trials that will test the effectiveness of vitamin B treatment in actual glaucoma patients and are hoping that the results will repeat those found in mice. This could provide an affordable and safe new alternative treatment to keep the eye cells from wearing down and becoming predisposed to developing glaucoma.
The team believes that a single gene therapy injection directly to the eye could provide the same results, which would be easier, especially for elderly patients who often have trouble remembering to take medication on a daily basis.